Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc.



    Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and
                               Theravance Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, August 27, 2013

LONDON, August 27, 2013 /PRNewswire/ --

The U.S. equity market slipped on Monday, August 26, 2013. All three benchmark
indexes closed lower, with the Dow Jones Industrial Average falling by 0.43%,
the S&P 500 falling by 0.40%, and the NASDAQ Composite declining by 0.01%.
Shares in the healthcare sector ended mostly higher even as the broader market
declined. The major movers in the sector included Alkermes PLC (NASDAQ: ALKS),
Hospira Inc. (NYSE: HSP), Celsion Corporation (NASDAQ: CLSN), and Theravance
Inc. (NASDAQ: THRX). All these companies are tracked by
AAAResearchReports.com. Free in-depth technical analysis on ALKS, HSP, CLSN,
and THRX are currently available upon sign up at:

http://www.aaaresearchreports.com/register/  

Alkermes PLC's stock ended 0.46% higher on Monday, reversing some of its
recent losses. The company's shares oscillated between $32.61 and $33.27
before finishing the day at $32.86. A total of 0.82 million shares were
traded, which is below the daily average volume of 1.41 million. The company's
shares have gained 0.09% in the last three trading sessions, underperforming
the S&P 500 which has gained 0.85% during the same period. Further, the
company's shares are trading above their 50-day and 200-day moving averages.
Sign up for free technical analysis on ALKS at:

http://www.AAAResearchReports.com/ALKS082713.pdf

Hospira Inc.'s stock ended almost flat on Monday, closing the day at $40.29,
0.02% lower than the previous closing price of $40.30. The company's shares
oscillated between $40.07 and $40.55. A total of 0.50 million shares were
traded, which is below the daily average volume of 0.91 million. The company's
shares have gained 2.03% in the last three trading sessions and 14.85% in the
last three months, outperforming the S&P 500 which has gained 0.85% and 0.44%
during the respective periods. Additionally, Hospira Inc.'s stock is trading
above its 50-day and 200-day moving averages. Download free report on HSP by
registering at:

http://www.AAAResearchReports.com/HSP082713.pdf

Celsion Corporation's stock gained 1.71% on Monday, even as the broader market
declined. The company's shares ended the day at $1.19 after fluctuating
between $1.16 and $1.19. A total of 0.84 million shares were traded, which is
below the daily average volume of 5.00 million. The company's shares have
advanced 5.31% in the last three trading sessions and 14.42% in the last three
months, outperforming the S&P 500 which has gained 0.85% and 0.44% during the
respective periods. Despite Monday's advances, the company's stock continues
to trade below its 50-day and 200-day moving averages. The free report on CLSN
can be downloaded by signing up now at:

http://www.AAAResearchReports.com/CLSN082713.pdf

Theravance Inc.'s shares surged on Monday, finishing the day 5.20% higher than
the previous day's closing price of $36.12. The company's shares oscillated
between $36.18 and $38.26 before ending the session at $38.00. A total of 0.81
million shares were traded, which is below the daily average volume of 1.09
million. The company's stock has gained 4.94% in the last three trading
sessions, compared to a gain of 0.85% in the S&P 500 during the same period.
Moreover, Theravance Inc.'s stock is currently trading above its 50-day and
200-day moving averages. A free report on THRX can be accessed by registering
at:

http://www.AAAResearchReports.com/THRX082713.pdf

----

EDITOR NOTES:

 1. This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
 2. Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA ® charterholder. However, we are only human
    and are prone to make mistakes. If you notice any errors or omissions,
    please notify us below.
 3. This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
 4. If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
 5. For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
 6. Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

AAAresearchreports.com

SOURCE AAA Research Reports

Contact: Phone #: + 1(646)396-9126, Contact Name: Peter F. Jones Email ID:
info@aaaresearchreports.com.
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement